Antipsychotic Agents: all 1,683 studies that test it

Page 5 of 17. Open to participants first (95), then studies with results posted, then the rest; newest registration first within each.

• Safety and Efficacy of Cariprazine for ManiaCompletedNCT01058096Phase 3Results posted
• A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in ChildrenCompletedNCT01050582Phase 4Results posted
• FMRI Brain Activation of Aripiprazole Treatment in Autism Spectrum DisordersCompletedNCT01028820Phase 4Results posted
• A Study to Evaluate Participants Satisfaction, Quality of Life and Effectiveness of Flexible-Dose of Paliperidone Extended Release (ER) in Participants With Schizophrenia, Previously Treated With RisperidoneCompletedNCT01010776Phase 4Results posted
• An Efficacy and Safety Study of Extended-Release (ER) Paliperidone in Adolescent Participants With SchizophreniaCompletedNCT01009047Phase 3Results posted
• Oral Aripiprazole Open-Label Rollover StudyCompletedNCT01001702Phase 3Results posted
• An Efficacy and Safety Study of Long Acting Injectable Risperidone and Oral Risperidone in Participants With Schizophrenia or Schizoaffective DisorderCompletedNCT00992407Phase 4Results posted
• Brain Imaging of Quetiapine Response in Anxious DepressionCompletedNCT00982345Phase 4Results posted
• A Study of Olanzapine in Patients With SchizophreniaCompletedNCT00970281Phase 3Results posted
• Study of Quetiapine Treatment for Cannabis DependenceCompletedNCT00954681Phase 2Results posted
• Efficacy and Safety of SEROQUEL Extended Release (XR) in Acute SchizophreniaCompletedNCT00954122Phase 4Results posted
• Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant DepressionCompletedNCT00953745Not applicableResults posted
• Cardiovascular Biomarkers and Quetiapine in Depression and Anxiety PatientsCompletedNCT00951483Phase 4Results posted
• Trial of Aripiprazole in TrichotillomaniaCompletedNCT00947154Not applicableResults posted
• 28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 YearsTerminatedNCT00946985Phase 4Results posted
• A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy ControlsTerminatedNCT00934635Phase 4Results posted
• Oculomotor and Spatial Cognition Deficits in SchizophreniaTerminatedNCT00931996Not applicableResults posted
• Fluphenazine Hydrochloride for PsoriasisCompletedNCT00929578Phase 2Results posted
• Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar DepressionCompletedNCT00926393Phase 4Results posted
• Examining the Effects of Antipsychotic Medications on Insulin SensitivityCompletedNCT00895921Phase 4Results posted
• Incomplete Response in Late Life Depression: Getting to Remission (IRL GREY)CompletedNCT00892047Phase 4Results posted
• Efficacy and Safety of Quetiapine Versus Quetiapine Plus Lithium in Bipolar DepressionCompletedNCT00883493Phase 3Results posted
• Efficacy and Safety of Quetiapine Fumarate in the Treatment of Schizophrenic PatientsCompletedNCT00882518Phase 3Results posted
• Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive DisorderCompletedNCT00882362Phase 3Results posted
• Seroquel Extended Release (XR) for the Management of Borderline Personality Disorder (BPD)CompletedNCT00880919Phase 3Results posted
• Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive DisorderCompletedNCT00876343Phase 3Results posted
• Staccato Loxapine Thorough QT/QTc StudyCompletedNCT00874237Phase 1Results posted
• Study of Aripiprazole in the Treatment of Pervasive Developmental DisordersCompletedNCT00870727Phase 3Results posted
• Lurasidone - A 24-week Extension Study of Patients With Bipolar I DepressionCompletedNCT00868959Phase 3Results posted
• Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)CompletedNCT00868699Phase 3Results posted
• Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)CompletedNCT00868452Phase 3Results posted
• Quetiapine Extended Release (XR) Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety DisorderTerminatedNCT00868374Phase 3Results posted
• Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With SchizophreniaCompletedNCT00862992Phase 2Results posted
• Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic SyndromeTerminatedNCT00857818Phase 3Results posted
• Quetiapine XR Versus Sertraline in Acute Bipolar Depression as add-on TherapyCompletedNCT00857584Phase 3Results posted
• Safety Study of Sertindole Versus Risperidone Under Normal Conditions of UseCompletedNCT00856583Phase 3Results posted
• Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive DisorderCompletedNCT00854100Phase 2Results posted
• Seroquel XR in Adults With SchizophreniaTerminatedNCT00852631Phase 3Results posted
• Safety and Efficacy of RGH-188 (Cariprazine) in Bipolar DepressionCompletedNCT00852202Phase 2Results posted
• Pharmacological Management of DeliriumCompletedNCT00842608Not applicableResults posted
• A Study of Cariprazine in Patients With Chronic Stable SchizophreniaCompletedNCT00839852Phase 2Results posted
• Staccato Loxapine in Migraine (Out Patient)CompletedNCT00825500Phase 2Results posted
• Pediatric Bipolar DepressionCompletedNCT00811473Phase 3Results posted
• Comparison of Optimal Antipsychotic Treatments for Adults With SchizophreniaCompletedNCT00802100Phase 4Results posted
• Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in SchizophreniaCompletedNCT00797277Phase 3Results posted
• Treatment of Severe Childhood Aggression (The TOSCA Study)CompletedNCT00796302Phase 4Results posted
• Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.CompletedNCT00790192Phase 3Results posted
• Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD PatientsCompletedNCT00789854Phase 3Results posted
• Staccato Loxapine Pulmonary Safety in Healthy VolunteersCompletedNCT00789360Phase 1Results posted
• Efficacy Study of Paliperidone to Evaluate Subjective Change in Well-being and Drug Attitude in Schizophrenic ParticipantsCompletedNCT00784238Phase 4Results posted
• Study of the Efficacy and Safety of Quetiapine Fumarate Extended Release (Seroquel XR)CompletedNCT00779506Phase 4Results posted
• Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691)CompletedNCT00764478Phase 3Results posted
• Phase 4 Study to Evaluate Efficacy of Paliperidone Extended-Release(ER) in Schizophrenic ParticipantsCompletedNCT00761605Phase 4Results posted
• Paliperidone Extended Release(ER) Effectiveness Study to Evaluate the Objective Symptom Change and Symptomatic RemissionCompletedNCT00761579Phase 4Results posted
• PaliperidoNe Extended-Release [ER] Dosing and Clinical Response in Acute SchizophreniaCompletedNCT00761189Phase 4Results posted
• An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended-Release (ER) in Participants With SchizophreniaCompletedNCT00757705Phase 4Results posted
• One-Year Trial Of Oral Ziprasidone In Patients With Metabolic SyndromeTerminatedNCT00748566Phase 4Results posted
• A New Pharmacotherapy for Alcohol Dependence: OlanzapineCompletedNCT00746785Phase 3Results posted
• Quetiapine XR for Cognitive and Functional Disability in Clinically Stable Patients With Bipolar DisorderTerminatedNCT00746421Phase 4Results posted
• Side Effect Study of Antipsychotic Medicines to Treat Childhood Bipolar DisorderTerminatedNCT00746252Not applicableResults posted
• Effect of Quetiapine on Marijuana Withdrawal and RelapseCompletedNCT00743366Phase 2Results posted
• A Crossover Study of the Acute Effects of Olanzapine in Healthy VolunteersCompletedNCT00741026Not applicableResults posted
• Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With SchizophreniaCompletedNCT00731549Phase 3Results posted
• A Randomized, Open-Label, Multi-Center Study To Evaluate The Efficacy And Safety Of Intramuscular Ziprasidone In Patients With AgitationCompletedNCT00723606Phase 3Results posted
• Actigraphic Analysis of Treatment ResponseCompletedNCT00723580Not applicableResults posted
• Staccato Loxapine in Agitated Patients With Bipolar DisorderCompletedNCT00721955Phase 3Results posted
• Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in SchizophreniaTerminatedNCT00712270Phase 4Results posted
• Study of SM-13496 (Lurasidone HCl) in Patients With SchizophreniaCompletedNCT00711269Phase 3Results posted
• Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With SchizophreniaCompletedNCT00706654Phase 3Results posted
• Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's DisorderCompletedNCT00706589Phase 3Results posted
• Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With SchizophreniaCompletedNCT00705783Phase 3Results posted
• A 4-week Study of Mifepristone in the Prevention of Risperidone-induced Weight Gain in Healthy Male VolunteersCompletedNCT00698022Phase 1Results posted
• Safety and Efficacy of Cariprazine (RGH-188) in the Acute Exacerbation of SchizophreniaCompletedNCT00694707Phase 2Results posted
• Effectiveness of Olanzapine Versus Placebo in Treating Outpatients With Anorexia NervosaCompletedNCT00692185Phase 2Results posted
• Effectiveness of Atypical Antipsychotic Medication for Outpatients With Anorexia NervosaCompletedNCT00685334Phase 4Results posted
• A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant TherapyCompletedNCT00683852Phase 3Results posted
• Quetiapine in Postpartum DepressionTerminatedNCT00681668Phase 2Results posted
• Seroquel for Frequent, Heavy DrinkersCompletedNCT00674765Phase 2Results posted
• Quetiapine Fumarate (Seroquel) as Mono-Therapy or Adjunct to Lithium in the Treatment of Patients With Acute Mania in Bipolar DisorderCompletedNCT00672490Phase 4Results posted
• Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD)CompletedNCT00671853Phase 3Results posted
• Anxiety in Recovering Opiate DependenceTerminatedNCT00668265Phase 4Results posted
• An Exploratory Study of Naltrexone Plus Aripiprazole for Alcohol DependenceCompletedNCT00667875Phase 2Results posted
• Study of Aripiprazole to Reduce Medical Risks in Bipolar DisorderTerminatedNCT00665444Not applicableResults posted
• Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I DisorderCompletedNCT00665366Phase 3Results posted
• Study in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible DoseTerminatedNCT00660595Phase 3Results posted
• A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease PsychosisCompletedNCT00658567Phase 3Results posted
• A 6 Month Study to Compare the Metabolic Effects of Paliperidone ER and Olanzapine in Patients With SchizophreniaCompletedNCT00645099Phase 3Results posted
• A 4-week, Randomized, Rater-blinded, Parallel Study to Evaluate Quetiapine in Improving Sleep Quality of SchizophreniaCompletedNCT00642369Not applicableResults posted
• Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable SchizophreniaCompletedNCT00641745Phase 3Results posted
• Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With SchizophreniaCompletedNCT00640601Phase 3Results posted
• Quetiapine Extended Release Depression SymptomsCompletedNCT00640562Phase 3Results posted
• A Study Comparing Rapid Acting Intramuscular Olanzapine and Placebo in Agitated Patients With SchizophreniaCompletedNCT00640510Phase 3Results posted
• Ziprasidone in the Psychosis ProdromeCompletedNCT00635700Phase 2Results posted
• Ziprasidone Augmentation of SSRIs for Patients With Major Depressive Disorder (MDD) That do Not Sufficiently Respond to Treatment With SSRIsCompletedNCT00633399Phase 2Results posted
• Double Blinded, Placebo-Controlled Trial of Paliperidone Addition in SRI-Resistant Obsessive-Compulsive DisorderCompletedNCT00632229Phase 2Results posted
• Quetiapine for the Reduction of Cocaine UseCompletedNCT00631748Not applicableResults posted
• Staccato Loxapine in Agitated Patients With SchizophreniaCompletedNCT00628589Phase 3Results posted
• Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct ProblemsCompletedNCT00626236Phase 2Results posted
• Ziprasidone in Pediatric Bipolar DisorderCompletedNCT00622739Phase 4Results posted
• A Study of Quetiapine SR (Seroquel SR) to Treat SSRI-Resistant, Comorbid Panic Disorder PatientsCompletedNCT00619892Phase 4Results posted

← Antipsychotic Agents overview